{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T05:02:17Z","timestamp":1794200537849,"version":"4.8.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Infections due to Gram-negative resistant bacterial pathogens are a major concern in intensive care units (ICUs). Risk factors for extended-spectrum beta-lactamase (ESBL)\u2013producing enterobacterales (ESBL-PE) and carbapenem-resistant enterobacterales (CRE) infections in pediatric critical care settings remain unclear.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This was a retrospective case-control study of infections due to ESBL-PE and CRE during a 5-year period (2016\u20132021). Control cases were matched for age, infection site and year of infection, but their cultures grew enterobacterales that were non-ESBL or carbapenemase producers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 57 patients with ESBL-PE or CRE infections (cases) and 59 control patients were included. The majority of organisms were <jats:italic toggle=\"yes\">Escherichia coli<\/jats:italic> and <jats:italic toggle=\"yes\">Klebsiella<\/jats:italic> species recovered from the respiratory tract. There was no difference in prior hospital admission, pediatric ICU, or neonatal ICU stay during the previous 6 months, indwelling devices, comorbid conditions, or surgery in the last 6 months (<jats:italic toggle=\"yes\">P<\/jats:italic> &gt; 0.3). Risk factors evaluated by univariate analysis included the history of antibiotic use in the last 6 months, antibiotic treatment with cephalosporins including cefepime, cephalosporins treatment duration \u22657 days, treatment with trimethoprim\/sulfamethoxazole and carbapenems and vancomycin use \u2265 7 days. However, multivariate logistic regression analysis showed that cefepime use \u2265 7 days was the single best predictor for cases with an odds ratio of 2.205-fold (95% confidence interval, 1.403\u20133.466; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Cefepime use \u2265 7 days was the most predictive risk factor of ESBL-PE and CRE acquisition. The study further underscores the need for optimizing antimicrobial stewardship practices to limit unnecessary and prolonged use of antibiotics to prevent the emergence of resistant pathogens.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004650","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T23:00:07Z","timestamp":1732575607000},"page":"422-427","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Risk Factors for Infections Caused by Extended-spectrum Beta-Lactamase Producing and Carbapenem-resistant Enterobacterales in Pediatric Critical Care Settings: A Case-control Study"],"prefix":"10.1097","volume":"44","author":[{"given":"Amr","family":"Omar","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Children\u2019s Hospital of Michigan, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basim I.","family":"Asmar","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Children\u2019s Hospital of Michigan, Detroit, Michigan"},{"name":"Department of Pediatrics, Central Michigan University, Mount Pleasant, Michigan"},{"name":"Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Ang","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Children\u2019s Hospital of Michigan, Detroit, Michigan"},{"name":"Department of Pediatrics, Central Michigan University, Mount Pleasant, Michigan"},{"name":"Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Salimnia","sequence":"additional","affiliation":[{"name":"Department of Pathology, Wayne State University, Detroit, Michigan"},{"name":"Detroit Medical Center University Laboratories, Detroit, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald A.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Central Michigan University, Mount Pleasant, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6957-4756","authenticated-orcid":false,"given":"Nahed","family":"Abdel-Haq","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Children\u2019s Hospital of Michigan, Detroit, Michigan"},{"name":"Department of Pediatrics, Central Michigan University, Mount Pleasant, Michigan"},{"name":"Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"issue":"5 Suppl 1","key":"R1-20250514","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ajic.2006.05.238","article-title":"Resistance in gram-negative bacteria: Enterobacteriaceae.","volume":"34","author":"Paterson","year":"2006","journal-title":"Am J Infect Control"},{"key":"R2-20250514","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/MOP.0000000000000182","article-title":"The contribution of extended-spectrum \u03b2-lactamases to multidrug-resistant infections in children.","volume":"27","author":"Murray","year":"2015","journal-title":"Curr Opin Pediatr"},{"key":"R3-20250514","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/cid\/cis543","article-title":"Carbapenem-resistant Enterobacteriaceae: an emerging problem in children.","volume":"55","author":"Logan","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R4-20250514","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.medmal.2013.11.007","article-title":"Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge.","volume":"44","author":"Nordmann","year":"2014","journal-title":"Med Mal Infect"},{"key":"R5-20250514","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/cid\/cis942","article-title":"Community-associated extended-spectrum \u03b2-lactamase-producing Escherichia coli infection in the United States.","volume":"56","author":"Doi","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R6-20250514","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/tropej\/fmp060","article-title":"Risk factors for extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae acquisition in a neonatal intensive care unit.","volume":"56","author":"Shakil","year":"2010","journal-title":"J Trop Pediatr"},{"key":"R7-20250514","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/jhin.2002.1373","article-title":"Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit: risk factors for infection and colonization.","volume":"53","author":"Pessoa-Silva","year":"2003","journal-title":"J Hosp Infect"},{"key":"R8-20250514","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jhin.2008.11.019","article-title":"Risk factors for colonisation of newborn infants during an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in an intermediate-risk neonatal unit.","volume":"71","author":"Cassettari","year":"2009","journal-title":"J Hosp Infect"},{"key":"R9-20250514","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1440-1754.2008.01326.x","article-title":"Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in paediatric wards: a nested case-control study.","volume":"44","author":"Demir","year":"2008","journal-title":"J Paediatr Child Health"},{"key":"R10-20250514","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/1471-2334-10-204","article-title":"High prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric unit in Madagascar.","volume":"10","author":"Andriatahina","year":"2010","journal-title":"BMC Infect Dis"},{"key":"R11-20250514","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/cid\/cir522","article-title":"Massive increase, spread, and exchange of extended spectrum \u03b2-lactamase-encoding genes among intestinal Enterobacteriaceae in hospitalized children with severe acute malnutrition in Niger.","volume":"53","author":"Woerther","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R12-20250514","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S1473-3099(19)30273-7","article-title":"Extended-spectrum \u03b2-lactamase-producing Escherichia coli in human-derived and foodchain-derived samples from England, Wales, and Scotland: an epidemiological surveillance and typing study.","volume":"19","author":"Day","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"R13-20250514","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/jpids\/piu011","article-title":"Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae infections in children: a two-center case-case-control study of risk factors and outcomes in Chicago, Illinois.","volume":"3","author":"Logan","year":"2014","journal-title":"J. Pediatric Infect Dis Soc"},{"key":"R14-20250514","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum beta-lactamases: a clinical update.","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"R15-20250514","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/2110-5820-1-47","article-title":"The rising problem of antimicrobial resistance in the intensive care unit.","volume":"1","author":"Brusselaers","year":"2011","journal-title":"Ann Intensive Care"},{"key":"R16-20250514","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1128\/AAC.01896-13","article-title":"Contemporary diversity of \u03b2-lactamases among Enterobacteriaceae in the nine U.S. census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent \u03b2-lactamase groups.","volume":"58","author":"Castanheira","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"R17-20250514","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3201\/eid2111.150548","article-title":"Carbapenem-resistant Enterobacteriaceae in children, United States, 1999-2012.","volume":"21","author":"Logan","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"R18-20250514","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1097\/INF.0000000000001499","article-title":"Clinical and bacterial risk factors for mortality in children with carbapenem-resistant Enterobacteriaceae bloodstream infections in India.","volume":"36","author":"Nabarro","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"R19-20250514","doi-asserted-by":"crossref","first-page":"ofy222","DOI":"10.1093\/ofid\/ofy222","article-title":"Increased 30-day mortality associated with carbapenem-resistant Enterobacteriaceae in children.","volume":"5","author":"Chiotos","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"R20-20250514","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13756-018-0336-y","article-title":"Estimating the burden of antimicrobial resistance: a systematic literature review.","volume":"7","author":"Naylor","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"key":"R21-20250514","doi-asserted-by":"crossref","first-page":"219","DOI":"10.12659\/MSM.892516","article-title":"Risk factors of carbapenem-resistant Klebsiella pneumoniae infection: a serious threat in ICUs.","volume":"21","author":"Candevir Ulu","year":"2015","journal-title":"Med Sci Monit"},{"key":"R22-20250514","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0195-6701(03)00153-1","article-title":"Bed occupancy and overcrowding as determinant factors in the incidence of MRSA infections within general ward settings.","volume":"54","author":"Borg","year":"2003","journal-title":"J Hosp Infect"},{"key":"R23-20250514","article-title":"CRE Technical Information.","year":"2019"},{"key":"R24-20250514","article-title":"VERIGENE\u00ae Gram-Negative Blood Culture Test.","year":"2024"},{"key":"R27-20250514","doi-asserted-by":"crossref","first-page":"e1730","DOI":"10.1128\/AAC.01730-17","article-title":"A systematic review and meta-analyses of the clinical epidemiology of carbapenem-resistant Enterobacteriaceae.","volume":"62","author":"van Loon","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"R28-20250514","doi-asserted-by":"crossref","first-page":"e01440","DOI":"10.1128\/AAC.01440-17","article-title":"Multicenter study of the risk factors for colonization or infection with carbapenem-resistant Enterobacteriaceae in children.","volume":"61","author":"Chiotos","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"R29-20250514","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/jac\/dkr116","article-title":"Antibiotic use and the risk of carbapenem-resistant extended-spectrum-{beta}-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study.","volume":"66","author":"Kritsotakis","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"R30-20250514","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/INF.0000000000001188","article-title":"Carbapenem-resistant Enterobacteriaceae infections in children: an Italian retrospective multicenter study.","volume":"35","author":"Montagnani","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R31-20250514","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/INF.0000000000000987","article-title":"Clinical characteristics of carbapenem-resistant Klebsiella pneumoniae infections in ill and colonized children in Colombia.","volume":"35","author":"D\u00edaz","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R32-20250514","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jiac.2020.10.017","article-title":"Acquisition of extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae in intensive care units in Thailand.","volume":"27","author":"Assawatheptawee","year":"2021","journal-title":"J Infect Chemother"},{"key":"R33-20250514","doi-asserted-by":"crossref","first-page":"R206","DOI":"10.1186\/cc10441","article-title":"Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of \u03b2-lactams.","volume":"15","author":"Gon\u00e7alves-Pereira","year":"2011","journal-title":"Crit Care"},{"key":"R34-20250514","first-page":"182","article-title":"Association of antibiotic utilization measures and reduced incidence of infections with extended-spectrum beta-lactamase-producing organisms.","volume":"36","author":"Lan","year":"2003","journal-title":"J Microbiol Immunol Infect"},{"key":"R35-20250514","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1086\/502304","article-title":"Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.","volume":"25","author":"Lee","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R36-20250514","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1128\/AAC.01020-07","article-title":"Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.","volume":"52","author":"Schwaber","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R37-20250514","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1099\/jmm.0.020214-0","article-title":"Acquisition of extended-spectrum beta-lactamase producing Escherichia coli strains in male and female infants admitted to a neonatal intensive care unit: molecular epidemiology and analysis of risk factors.","volume":"59","author":"Shakil","year":"2010","journal-title":"J Med Microbiol"},{"key":"R38-20250514","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/jama.281.6.517","article-title":"Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.","volume":"281","author":"Wiener","year":"1999","journal-title":"JAMA"},{"key":"R39-20250514","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.diagmicrobio.2005.09.011","article-title":"Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance Program.","volume":"54","author":"Bhavnani","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R40-20250514","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13756-019-0572-9","article-title":"Extended spectrum beta-lactamase producing enterobacterales faecal carriage in a medical intensive care unit: low rates of cross-transmission and infection.","volume":"8","author":"Prevel","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"R41-20250514","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/jama.2020.2717","article-title":"Prevalence and outcomes of infection among patients in intensive care units in 2017.","volume":"323","author":"Vincent","year":"2020","journal-title":"JAMA"},{"key":"R42-20250514","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1128\/AAC.00126-09","article-title":"Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258.","volume":"53","author":"Kitchel","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R43-20250514","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/00365548.2011.592987","article-title":"Long-term carriage of extended-spectrum beta-lactamase-producing Escherichia coli.","volume":"44","author":"Alsterlund","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"R44-20250514","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/jac\/dks502","article-title":"Long-term faecal carriage in infants and intra-household transmission of CTX-M-15-producing Klebsiella pneumoniae following a nosocomial outbreak.","volume":"68","author":"L\u00f6hr","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"R45-20250514","doi-asserted-by":"crossref","first-page":"46.e1","DOI":"10.1016\/j.cmi.2016.08.021","article-title":"Quantifying within-household transmission of extended-spectrum \u03b2-lactamase-producing bacteria.","volume":"23","author":"Haverkate","year":"2017","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 7","key":"R46-20250514","doi-asserted-by":"crossref","first-page":"S565","DOI":"10.1093\/cid\/ciz830","article-title":"Treatment Options for Carbapenem-resistant Gram-negative bacterial infections.","volume":"69","author":"Doi","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R47-20250514","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/cid\/ciac268","article-title":"Infectious Diseases Society of America 2022 guidance on the treatment of extended-spectrum \u03b2-lactamase producing enterobacterales (ESBL-E), carbapenem-resistant enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa).","volume":"75","author":"Tamma","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R48-20250514","doi-asserted-by":"crossref","first-page":"h6420","DOI":"10.1136\/bmj.h6420","article-title":"Antibiotic resistance in Enterobacteriaceae: mechanisms and clinical implications.","volume":"352","author":"Iredell","year":"2016","journal-title":"BMJ"},{"key":"R49-20250514","doi-asserted-by":"crossref","first-page":"ofaa299","DOI":"10.1093\/ofid\/ofaa299","article-title":"The clinical and molecular epidemiology of noncarbapenemase-producing carbapenem-resistant Enterobacteriaceae: a case-case-control matched analysis.","volume":"7","author":"Bouganim","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"R50-20250514","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1017\/ice.2019.5","article-title":"ESBL-colonization at ICU admission: impact on subsequent infection, carbapenem-consumption, and outcome.","volume":"40","author":"Emmanuel Martinez","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R51-20250514","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/1040841X.2013.875515","article-title":"Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients - review of the literature from a clinical perspective.","volume":"42","author":"Biehl","year":"2016","journal-title":"Crit Rev Microbiol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004650","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T21:14:10Z","timestamp":1747257250000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004650","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,22]]}}}